Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login

Urology Journal

  • Home
  • Instant Online
    • Instant 2026
    • Instant 2023
    • Instant 2021
    • Instant 2020
  • Current
  • Archives
  • Announcements
  • Submissions
  • Author Guidelines
  • About
    • About the Journal
    • Editorial Team
    • Privacy Statement
    • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 2 No. 2 (2005): Spring
  4. ORIGINAL PAPER (ENDOUROLOGY AND STONE DISEASE)

Vol. 2 No. 2 (2005)

May 2009

Urinary Tamm-Horsfall Protein and Citrate: A Case-Control Study of Inhibitors and Promoters of Calcium Stone Formation

  • Gholamreza Pourmand
  • Hamidreza Nasseh
  • Abdolfattah Sarrafnejad
  • Abdolrasoul Mehrsai
  • Darioush Hamidi Alamdari
  • Keramat Nourijelyani
  • Leila Shekarpour

Urology Journal, Vol. 2 No. 2 (2005), 13 May 2009 , Page 79-85
https://doi.org/10.22037/uj.v2i2.254 Published: 2009-05-13

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: This study aimed to compare urinary Tamm-Horsfall protein (THP), citrate, and other inhibitors and promoters of stone formation in calcium stone formers with those in healthy individuals.

Materials and Methods: From January 2002 to June 2004, 100 calcium stone formers (mean age, 38.6 ± 10.3 years) who had at least 2 episodes of calcium stone formation were compared with 100 healthy individuals (mean age, 33.8 ± 9.7 years). Their 24-hour urine THP (using the sodium dodecyl sulfate polyacrylamide gel electrophoresis method), citrate, calcium, uric acid, oxalate, and magnesium values were measured and compared.

Results: The mean 24-hour urine THP was 3.3 ± 8.1 mg in patients in the study group and 4.6 ± 19.2 mg in controls (P = 0.5). However, THP in individuals with and without bacteriuria was significantly different (15.8 ± 33.6 versus 2.6 ± 10.2, P < 0.001). Mean 24-hour urinary calcium, citrate, and oxalate values were 232.6 ± 95.3 mg and 177.8 ± 82.7 mg (P < 0.001), 132 ± 103.2 mg and 395 ± 258.5 mg (P < 0.001), and 18.9 ± 22.5 mg and 10.4 ± 8.5 mg (P < 0.001) in patients in the study and control groups, respectively. There was a significant positive correlation between urinary citrate and promoters of stone formation, including urinary calcium, oxalate, and uric acid, in patients in the control group, but not in patients in the study group.

Conclusion: THP in the urine of stone formers is not quantitatively different from that of healthy individuals, but it is different in patients with bacteriuria. Increased urinary excretion of calcium, oxalate, and uric acid in stone formers with no increase in urine citrate may play a role in the pathogenesis of recurrent stone formation.

  • PDF

How to Cite

Pourmand, G., Nasseh, H., Sarrafnejad, A., Mehrsai, A., Hamidi Alamdari, D., Nourijelyani, K., & Shekarpour, L. (2009). Urinary Tamm-Horsfall Protein and Citrate: A Case-Control Study of Inhibitors and Promoters of Calcium Stone Formation. Urology Journal, 2(2), 79–85. https://doi.org/10.22037/uj.v2i2.254
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 304 times
  • PDF Downloaded: 358 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus